Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SST-0225 for DOMS
NCT02339129Phase 2Completed
- Sponsor
- Strategic Science & Technologies
- Start
- Nov 2014
- Primary completion
- Feb 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SST-0225 in delayed onset muscle soreness (DOMS), sponsored by Strategic Science & Technologies. Started Nov 2014; status: completed.
02
Drugs
SST-0225
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT02339129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339129.